Camurus AB (publ) (CAMX.ST)
SEK 574.5
(1.77%)
SEK 574.5
(1.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.58 Billion SEK | 85.27% |
| 2022 | 853.07 Million SEK | 65.58% |
| 2021 | 515.21 Million SEK | 71.33% |
| 2020 | 300.71 Million SEK | 265.31% |
| 2019 | 82.31 Million SEK | 93.69% |
| 2018 | 42.49 Million SEK | -19.74% |
| 2017 | 52.95 Million SEK | -52.55% |
| 2016 | 111.59 Million SEK | -27.8% |
| 2015 | 154.56 Million SEK | -25.53% |
| 2014 | 207.55 Million SEK | 5.82% |
| 2013 | 196.14 Million SEK | 113.47% |
| 2012 | 91.88 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 359.13 Million SEK | 6.22% |
| 2024 Q2 | 409.31 Million SEK | 13.97% |
| 2023 Q3 | 351.99 Million SEK | -45.45% |
| 2023 Q1 | 255.24 Million SEK | 6.34% |
| 2023 FY | 1.58 Billion SEK | 85.27% |
| 2023 Q4 | 338.1 Million SEK | -3.94% |
| 2023 Q2 | 645.27 Million SEK | 152.81% |
| 2022 Q4 | 240.02 Million SEK | 10.44% |
| 2022 Q1 | 194.09 Million SEK | 25.52% |
| 2022 Q2 | 201.61 Million SEK | 3.87% |
| 2022 Q3 | 217.33 Million SEK | 7.79% |
| 2022 FY | 853.07 Million SEK | 65.58% |
| 2021 Q4 | 154.63 Million SEK | 16.22% |
| 2021 Q2 | 117.3 Million SEK | 6.42% |
| 2021 Q1 | 110.22 Million SEK | 18.41% |
| 2021 FY | 515.21 Million SEK | 71.33% |
| 2021 Q3 | 133.05 Million SEK | 13.43% |
| 2020 Q3 | 89.61 Million SEK | 17.15% |
| 2020 Q4 | 93.08 Million SEK | 3.87% |
| 2020 FY | 300.71 Million SEK | 265.31% |
| 2020 Q1 | 41.51 Million SEK | 93.25% |
| 2020 Q2 | 76.49 Million SEK | 84.26% |
| 2019 Q1 | 15.49 Million SEK | 300.65% |
| 2019 Q3 | 35.4 Million SEK | 256.48% |
| 2019 FY | 82.31 Million SEK | 93.69% |
| 2019 Q2 | 9.93 Million SEK | -35.91% |
| 2019 Q4 | 21.48 Million SEK | -39.32% |
| 2018 Q4 | 3.86 Million SEK | -80.1% |
| 2018 FY | 42.49 Million SEK | -19.74% |
| 2018 Q3 | 19.44 Million SEK | 218.81% |
| 2018 Q2 | 6.09 Million SEK | -53.42% |
| 2018 Q1 | 13.09 Million SEK | 178.32% |
| 2017 FY | 52.95 Million SEK | -52.55% |
| 2017 Q4 | 4.7 Million SEK | -63.95% |
| 2017 Q3 | 13.05 Million SEK | -27.65% |
| 2017 Q2 | 18.03 Million SEK | 5.11% |
| 2017 Q1 | 17.16 Million SEK | -52.2% |
| 2016 Q2 | 25.53 Million SEK | 26.5% |
| 2016 Q3 | 29.98 Million SEK | 17.45% |
| 2016 Q4 | 35.89 Million SEK | 19.72% |
| 2016 FY | 111.59 Million SEK | -27.8% |
| 2016 Q1 | 20.18 Million SEK | -44.3% |
| 2015 Q1 | 58.54 Million SEK | -59.56% |
| 2015 Q2 | 22.68 Million SEK | -61.25% |
| 2015 Q3 | 37.1 Million SEK | 63.54% |
| 2015 Q4 | 36.23 Million SEK | -2.33% |
| 2015 FY | 154.56 Million SEK | -25.53% |
| 2014 FY | 207.55 Million SEK | 5.82% |
| 2014 Q4 | 144.74 Million SEK | 324.72% |
| 2014 Q3 | 34.08 Million SEK | 0.0% |
| 2013 FY | 196.14 Million SEK | 113.47% |
| 2012 FY | 91.88 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | -160.68 Million SEK | 1083.611% |
| Ziccum AB (publ) | -23.28 Million SEK | 6887.404% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | 346.31 Million SEK | -356.378% |
| Sprint Bioscience AB (publ) | 41.78 Million SEK | -3682.313% |
| Mendus AB (publ) | 28.48 Million SEK | -5448.197% |
| Genovis AB (publ.) | 54 Million SEK | -2826.825% |
| Intervacc AB (publ) | -13.79 Million SEK | 11557.989% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 2.17 Million SEK | -72701.244% |
| Active Biotech AB (publ) | -1.67 Million SEK | 94459.104% |
| Magle Chemoswed Holding AB (publ) | 9.96 Million SEK | -15763.846% |
| Bio-Works Technologies AB (publ) | 26.82 Million SEK | -5792.827% |
| Aptahem AB (publ) | 2.63 Million SEK | -59980.824% |
| Vicore Pharma Holding AB (publ) | -3.42 Million SEK | 46300.38% |
| Kancera AB (publ) | -1.96 Million SEK | 80533.333% |
| Infant Bacterial Therapeutics AB (publ) | 77 Thousand SEK | -2052516.883% |
| Fluicell AB (publ) | 1.73 Million SEK | -90838.723% |
| Saniona AB (publ) | 11.78 Million SEK | -13315.797% |
| Lipigon Pharmaceuticals AB (publ) | -5.11 Million SEK | 30987.532% |
| Biovica International AB (publ) | 6.87 Million SEK | -22882.623% |
| Spago Nanomedical AB (publ) | -23.28 Million SEK | 6888.279% |
| AcouSort AB (publ) | 8.38 Million SEK | -18740.327% |
| Xintela AB (publ) | 78 Thousand SEK | -2026201.282% |
| Abliva AB (publ) | -35.66 Million SEK | 4531.806% |
| Egetis Therapeutics AB (publ) | -146.9 Million SEK | 1175.912% |
| Karolinska Development AB (publ) | 2.8 Million SEK | -56206.199% |
| OncoZenge AB (publ) | 3000.00 SEK | -52683733.333% |
| Amniotics AB (publ) | -1.93 Million SEK | 81991.969% |
| 2cureX AB (publ) | -37.48 Million SEK | 4316.168% |
| CombiGene AB (publ) | -21.29 Million SEK | 7523.504% |
| Asarina Pharma AB (publ) | -423 Thousand SEK | 373744.208% |
| Calliditas Therapeutics AB (publ) | 1.12 Billion SEK | -39.89% |
| Corline Biomedical AB | 28.38 Million SEK | -5469.116% |
| IRLAB Therapeutics AB (publ) | -122.73 Million SEK | 1387.756% |
| Isofol Medical AB (publ) | -34.41 Million SEK | 4692.518% |
| I-Tech AB | 27.56 Million SEK | -5633.567% |
| Hansa Biopharma AB (publ) | 70.95 Million SEK | -2127.615% |
| Cyxone AB (publ) | 2.61 Million SEK | -60432.938% |
| ExpreS2ion Biotech Holding AB (publ) | 3.4 Million SEK | -46344.755% |
| Biosergen AB | -456 Thousand SEK | 346704.167% |
| Cantargia AB (publ) | -3.45 Million SEK | 45898.754% |
| NextCell Pharma AB | -43.74 Million SEK | 3712.759% |
| Xspray Pharma AB (publ) | -9.19 Million SEK | 17290.722% |
| Elicera Therapeutics AB (publ) | 11.21 Million SEK | -13988.737% |
| Nanologica AB (publ) | -76 Thousand SEK | 2079725.0% |
| SynAct Pharma AB | -778 Thousand SEK | 203251.028% |
| Annexin Pharmaceuticals AB (publ) | -193 Thousand SEK | 819019.689% |
| Stayble Therapeutics AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | -12.92 Million SEK | 12331.195% |
| Lipum AB (publ) | 53 Thousand SEK | -2982003.774% |
| BioInvent International AB (publ) | 71.46 Million SEK | -2111.717% |
| Alzinova AB (publ) | 19.87 Million SEK | -7852.677% |
| Oncopeptides AB (publ) | 36.29 Million SEK | -4254.156% |
| Pila Pharma AB (publ) | 1.46 Million SEK | -107930.991% |
| Guard Therapeutics International AB (publ) | -15 Thousand SEK | 10536866.667% |
| Scandinavian ChemoTech AB (publ) | 1.65 Million SEK | -95226.598% |
| Simris Alg AB (publ) | 2 Million SEK | -78650.125% |
| Diamyd Medical AB (publ) | -3.58 Million SEK | 44248.464% |
| Xbrane Biopharma AB (publ) | 35.38 Million SEK | -4366.246% |
| Ascelia Pharma AB (publ) | -1.04 Million SEK | 150768.732% |
| Diagonal Bio AB (publ) | 3.13 Million SEK | -50347.335% |